TipRanks
Go Ultimate55% OFF

Compare Intellia Therapeutics (38I) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:38IIntellia TherapeuticsEUR 11.12EUR 1.56B-3.718.07%Moderate BuyDE:38I
KURAKura Oncology$10.26$912.74M-3.04-1.72%Strong BuyDE:38I vs KURA
CMPXCompass Therapeutics$0.79$141.64M-1.90-78.87%Strong BuyDE:38I vs CMPX
ABCLAbCellera Biologics$12.27$3.98B-22.72128.92%Strong BuyDE:38I vs ABCL
JANXJanux Therapeutics Inc$17.47$1.07B-10.59-38.72%Strong BuyDE:38I vs JANX
BCAXBicara Therapeutics Inc.$9.13$604.16M-2.94-44.53%Moderate BuyDE:38I vs BCAX

Performance Comparison

-100%-50%0%50%100%150%200%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:38IIntellia Therapeutics11.120.222.02%
KURAKura Oncology10.260.495.02%
CMPXCompass Therapeutics0.79-2.95-78.98%
ABCLAbCellera Biologics12.276.90128.49%
JANXJanux Therapeutics Inc17.47-9.90-36.17%
BCAXBicara Therapeutics Inc.9.13-6.85-42.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts